Author

Mark H. Perrone

Observed names: M H Perrone, M Perrone, M. H. PERRONE, M. H. Perrone, M.H. Perrone, MARK H. PERRONE, MH Perrone, Mark H Perrone, Mark Perrone, MarkH. Perrone, Perrone, Mark

Observed institutions: Genomics Institute of the Novartis Research Foundation, New York State Department of Health, Wadsworth Center, Harvard University, Maryville College, Eli Lilly (United States), Cornell University, University of Rochester Medicine, Abbott (United States), Bristol-Myers Squibb (United States), Merrimack Pharmaceuticals (United States), University of Rochester

OpenAlex ID: A5110101723

A novel endothelial-derived lipase that modulates HDL metabolism

1999 · Michael Jaye, Kevin J. Lynch, et al. · Nature Genetics · 499

Evidence for L-glutamate as the Neurotransmitter of Baroreceptor Afferent Nerve Fibers

1980 · William T. Talman, Mark H. Perrone, et al. · Science · 451

Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.

1992 · D Amin, SA Cornell, et al. · Journal of Lipid Research · 281

Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin

1993 · D. A. Scheuer, M. H. Perrone · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 135

Evidence that glutamic acid is the neurotransmitter of baroreceptor afferents terminating in the nucleus tractus solitarius (NTS)

1981 · Donald J. Reis, Antonio R. Granata, et al. · Journal of the Autonomic Nervous System · 127

Acute hypertension after the local injection of kainic acid into the nucleus tractus solitarii of rats.

1981 · W T Talman, M H Perrone, et al. · Circulation Research · 125

PDF

Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells

1991 · G. E. Bilder, J. A. Krawiec, et al. · American Journal of Physiology-Cell Physiology · 116

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

1988 · Paul J. Silver, Linda T. Hamel, et al. · European Journal of Pharmacology · 110

Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.

1992 · L A Merkel, R W Lappe, et al. · Journal of Pharmacology and Experimental Therapeutics · 106

Jaye, M. et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21, 424-428

1999 · Michael Jaye, Kevin J. Lynch, et al. · 101

Regulation of pituitary receptors for thyrotropin-releasing hormone by thyroid hormones.

1978 · M.H. Perrone, P.M. Hinkle · Journal of Biological Chemistry · 95

PDF

Biochemical evidence thatl-glutamate is a neurotransmitter of primary vagal afferent nerve fibers

1981 · Mark H. Perrone · Brain Research · 93

Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A

1999 · Glenda Bilder, Tara Wentz, et al. · Circulation · 89

Cardioprotective Effects of the Novel Adenosine A1/A2 Receptor Agonist AMP 579 in a Porcine Model of Myocardial Infarction

1998 · G.J. Smits, M. McVey, et al. · Journal of Pharmacology and Experimental Therapeutics · 84

Activation of β‐Adrenergic Receptors Stimulates Release of an Inhibitory Transmitter from Astrocytes

1986 · William Shain, Vergine Madelian, et al. · Journal of Neurochemistry · 72

RPR 107393, a Potent Squalene Synthase Inhibitor and Orally Effective Cholesterol-Lowering Agent: Comparison with Inhibitors of HMG-CoA Reductase

1997 · Dilip Amin, Ruth Z. Rutledge, et al. · Journal of Pharmacology and Experimental Therapeutics · 69

1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.

1996 · D Amin, S A Cornell, et al. · PubMed · 65

Antagonism of the baroreceptor reflex by glutamate diethyl ester, an antagonist to L-glumate

1981 · William T. Talman, Mark H. Perrone, et al. · Brain Research · 63

Pharmacology of pravadoline: a new analgesic agent.

1990 · D R Haubrich, S J Ward, et al. · Journal of Pharmacology and Experimental Therapeutics · 61

Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.

1989 · A L Harris, B M Lemp, et al. · Journal of Pharmacology and Experimental Therapeutics · 61

Mechanism of Thyroid Hormone Inhibition of Thyrotropin-Releasing Hormone Action*

1981 · PATRICIA M. HINKLE, MARK H. PERRONE, et al. · Endocrinology · 61

The promise of genomics to identify novel therapeutic targets

2004 · Anthony P Orth, Serge Batalov, et al. · Expert Opinion on Therapeutic Targets · 56

Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension

2004 · Mark C. Kowala, Natesan Murugesan, et al. · Journal of Pharmacology and Experimental Therapeutics · 52

Pharmacological analysis of alpha-2 adrenergic mechanisms in nociception and ataxia.

1985 · D Luttinger, R Ferrari, et al. · Journal of Pharmacology and Experimental Therapeutics · 51

Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis

2000 · H Zhu, S McElwee-Witmer, et al. · Cell Death and Differentiation · 49

Works count: 96

Citation count: 4,297

H-index: 34

I10-index: 75